Brief: Pediapharm Reports Q2 Total Rev Of $3.4 Mln Versus $3.1 Mln
Nov 27 (Reuters) - Pediapharm Inc PDP.V :
* PEDIAPHARM ANNOUNCES Q2 RESULTS – RECORD ADJUSTED EBITDA,
RECORD
REVENUE AND 13TH CONSECUTIVE YEAR-OVER-YEAR QUARTERLY REVENUE
GROWTH
* PEDIAPHARM INC - QTRLY TOTAL REVENUE $3.4 MILLION VERSUS
$3.1
MILLION
Source text for Eikon: ID:nGNX2JQLsQ
Further company coverage: PDP.V
(Reuters.Briefs@thomsonreuters.com)
Recent news on Medexus Pharmaceuticals
See all newsCanada's Medexus Q4 revenue misses analyst expectations, net loss widens
Brief: Medexus Pharmaceuticals Q4 Revenue USD 24.652 Million Vs. IBES Estimate USD 25.6 Million
Canada Research Roundup: CAE, Medexus Pharmaceuticals, TCP Energy
Medexus Pharma Q2 revenue misses estimates
Brief: Medexus Pharmaceuticals Q2 Revenue USD 24.741 Million Vs. IBES Estimate USD 25.6 Million